Daily Stock Analysis, NVRO, Nevro Corp, priceseries

Nevro Corp. Daily Stock Analysis
Stock Information
Open
69.75
Close
65.30
High
69.83
Low
65.27
Previous Close
69.50
Daily Price Gain
-4.20
YTD High
93.69
YTD High Date
Jan 12, 2022
YTD Low
60.59
YTD Low Date
Feb 24, 2022
YTD Price Change
-19.97
YTD Gain
-23.42%
52 Week High
182.45
52 Week High Date
Jun 23, 2021
52 Week Low
60.59
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-74.65
52 Week Gain
-53.34%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 3. 2017
75.17
Jan 24. 2017
85.88
14 Trading Days
14.25%
Link
LONG
Jan 31. 2017
87.02
Feb 23. 2017
94.68
16 Trading Days
8.80%
Link
LONG
Mar 19. 2019
44.77
Apr 22. 2019
64.20
23 Trading Days
43.40%
Link
LONG
Aug 9. 2019
74.46
Sep 18. 2019
86.23
27 Trading Days
15.81%
Link
LONG
Jul 14. 2020
118.97
Jul 28. 2020
128.68
10 Trading Days
8.16%
Link
LONG
Oct 7. 2020
144.80
Oct 27. 2020
155.30
14 Trading Days
7.25%
Link
LONG
Nov 4. 2020
154.77
Nov 25. 2020
169.14
15 Trading Days
9.28%
Link
LONG
Apr 20. 2021
155.32
May 4. 2021
164.91
10 Trading Days
6.18%
Link
LONG
Jun 7. 2021
151.74
Jun 28. 2021
165.67
15 Trading Days
9.18%
Link
Company Information
Stock Symbol
NVRO
Exchange
NYSE
Company URL
http://www.nevro.com
Company Phone
650-251-0005
CEO
Rami Elghandour
Headquarters
California
Business Address
1800 BRIDGE PARKWAY, REDWOOD CITY, CA 94065
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001444380
About

Nevro Corp. engages in the development and manufacture of medical devices. The company develops and commercializes neuromodulation platform for the treatment of chronic pain. It offers a spinal cord stimulation system under the Senza, HF10, and Nevro brands. The company was founded in March 2006 and is headquartered in Redwood City, CA.

Description

Nevro Corp., a medical device company, focuses on providing products for the patients suffering from chronic pain in the United States and internationally. It develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.